KBC Group’s Core Scientific CORZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212K Hold
8,300
﹤0.01% 1021
2026
Q1
$124K Hold
8,300
﹤0.01% 1200
2025
Q4
$121K Hold
8,300
﹤0.01% 1164
2025
Q3
$149K Hold
8,300
﹤0.01% 1035
2025
Q2
$142K Sell
8,300
-2,587
-24% -$25.9K ﹤0.01% 1016
2025
Q1
$79K Buy
10,887
+2,805
+35% +$31.9K ﹤0.01% 1600
2024
Q4
$114K Buy
+8,082
New +$119K ﹤0.01% 1465

Other funds holding CORZ

KBC Group's CORZ Position: Q2 2026 in Review

KBC Group held its Core Scientific (CORZ) position steady in Q2 2026 at 8,300 shares worth $212K. The position accounts for ﹤0.01% of the portfolio, ranked #1021.

KBC Group first reported a position in CORZ in Q4 2024 and has held it in 7 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • KBC Group held 8,300 shares of Core Scientific worth $212K as of Q2 2026.
  • KBC Group left its Core Scientific share count unchanged in Q2 2026.
  • Core Scientific made up ﹤0.01% of KBC Group's portfolio in Q2 2026, its #1021 holding.
  • KBC Group first reported a position in Core Scientific in Q4 2024 and has held it in 7 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.